schliessen

Filtern

 

Bibliotheken

1.

A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.
by Goulart, Bernardo

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2011 Sep-Oct, Vol.14(6), pp.836-845

3.

Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.
by Lang, Kathleen

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, June 2009, Vol.12(4), pp.481-488

1

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 3 Hits

Remove Filters